First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer.

Wu, Jenn-YuJenn-YuWuYu, Chong-JenChong-JenYuChih-HsinYangWu, Shang-GinShang-GinWuChiu, Yueh-HsiaYueh-HsiaChiuGow, Chien-HungChien-HungGowChang, Yeun-ChungYeun-ChungChangHsu, Ya-ChiehYa-ChiehHsuWei, Pin-FeiPin-FeiWeiShih, Jin-YuanJin-YuanShihYang, Pan-ChyrPan-ChyrYang2011-02-142018-07-122011-02-142018-07-122008-10http://ntur.lib.ntu.edu.tw//handle/246246/224771en-US[SDGs]SDG3First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer.